NASDAQ: JSPRJasper Therapeutics Inc Earnings Dates, Reports, Calls
Jasper Therapeutics earnings were -$90.9M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest JSPR earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$26.7M, up 25.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, JSPR reported annual earnings of -$71.3M, with 10.6% growth.
JSPR earnings history
Current Revenue
$0.0
Current Earnings
-$90.9M
Current Profit Margin
0%
JSPR Return on Equity
Current Company
-172.3%
Current Industry
-9%
Current Market
27%
JSPR's Return on Equity (-172.3%)... subscribe to Premium to read more.
High Return on Equity Performance
JSPR undefined
Current Company
-128.3%
Current Industry
0.3%
JSPR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when JSPR announces earnings.
JSPR undefined
Current Company
-350.16%
Current Industry
8.2%
JSPR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
JSPR vs Biotech Stocks
Jasper Therapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.